CIK 0001658551 · Non-accelerated filer<br>Smaller reporting company
Amylyx Pharmaceuticals, Inc.
Sign in to watch- Ticker
- AMLX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464600503
- Phone
- 617-682-0917
- Business address
- 55 CAMBRIDGE PARKWAY, SUITE 6W, CAMBRIDGE, MA, 02142
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $10,951,125
- in 9 filings, $8.0M under 10b5-1 plans
Net −$10,951,125. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Cohen Joshua B −$4.0M Co-Chief Executive Officer sold 4% of stake
- Klee Justin B. −$4.0M Co-Chief Executive Officer sold 4% of stake
- FRATES JAMES M −$1.6M Chief Financial Officer sold 18% of stake
- MILNE GEORGE M JR −$831K Director sold 4% of stake
- Bedrosian Camille L −$325K Chief Medical Officer sold 3% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-10-31 | FRATES JAMES M Chief Financial Officer | Gift | +11,072 | 11,072 | ||
| 2023-08-23 | FRATES JAMES M Chief Financial Officer | Option exercise | +18,165 | $6.88 | $125K | 73,841 |
| 2023-08-23 | FRATES JAMES M Chief Financial Officer | Option exercise · Stock Option (right to buy) | −18,165 | 363,835 | ||
| 2023-08-23 | FRATES JAMES M Chief Financial Officer | Option exercise | +18,165 | $6.88 | $125K | 106,341 |
| 2023-08-23 | FRATES JAMES M Chief Financial Officer | Option exercise · Stock Option (right to buy) | −18,165 | 363,835 | ||
| 2023-08-15 | Mazzariello Gina Chief Legal Officer | Sale 10b5-1 | −6,164 | $20.88 | $129K | 49,083 |
| 2023-08-15 | Morningside Venture Investments Ltd 10% owner | Gift | −2,000,000 | 4,997,302 | ||
| 2023-07-12 | Olinger Margaret Chief Commercial Officer | Option exercise | +20,000 | $0.37 | $7K | 251,108 |
| 2023-07-12 | Olinger Margaret Chief Commercial Officer | Option exercise · Stock Option (Right to Buy) | −20,000 | 69,577 | ||
| 2023-06-08 | Firestone Karen Director | Grant or award · Stock Option (right to buy) | +3,908 | 3,908 | ||
| 2023-06-08 | MILNE GEORGE M JR Director | Grant or award · Stock Option (right to buy) | +16,985 | 16,985 | ||
| 2023-06-08 | Quimi Daphne Director | Grant or award · Stock Option (right to buy) | +16,985 | 16,985 | ||
| 2023-06-08 | FONTEYNE PAUL R. Director | Grant or award · Stock Option (right to buy) | +16,985 | 16,985 | ||
| 2023-05-22 | Olinger Margaret Chief Commercial Officer | Gift | −1,580 | 231,108 | ||
| 2023-05-17 | Mazzariello Gina Chief Legal Officer | Gift | −500 | 55,247 | ||
| 2023-05-16 | FRATES JAMES M Chief Financial Officer | Option exercise 10b5-1 | +32,500 | $6.88 | $224K | 88,176 |
| 2023-05-16 | FRATES JAMES M Chief Financial Officer | Sale 10b5-1 | −32,000 | $26.93 | $862K | 56,176 |
| 2023-05-16 | FRATES JAMES M Chief Financial Officer | Sale 10b5-1 | −500 | $27.60 | $14K | 55,676 |
| 2023-05-16 | FRATES JAMES M Chief Financial Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −32,500 | 382,000 | ||
| 2023-05-15 | Yeramian Patrick D Chief Medical Officer | Option exercise 10b5-1 | +2,201 | $0.37 | $814 | 210,618 |
Page 10 of 19 · 362 trades